bioMérieux has just acquired a stake in Allergen Alert, an innovative startup specializing in the rapid detection of food allergens for individuals and professionals.
Asset acquisition would expand Merit’s Endoscopy portfolio with an innovative device to treat patients suffering from Barretts esophagus and other gastrointestinal disorders.
AI-powered voice analysis expands to detect verbal aggression and prevent nurse burnout through real-time vocal biomarker technology, enhancing clinician safety and patient care
Owlet expands its global footprint, entering one of the world’s most promising digital health markets, with CDSCO-approved technology.
AGREEMENT INCLUDES ACTINIUM-225 (AC-225) AND LUTETIUM-177 (LU-177) TO SUPPORT ARICEUM’S THERAPEUTIC PROGRAMS
In-vitro studies confirm that the Company’s novel Smart mRNA could drastically reduce off-target liver toxicity, a major issue affecting many cancer drugs
Halia Therapeutics Expands to Abu Dhabi
Leash Bio Announces Multi-Target Agreement with Monte Rosa Therapeutics
SCOUT Radar Localization use grows, supporting more successful surgeries and improved patient care.
Attendees invited to Booth #732 for pivotal trial updates and to discuss unmet needs in Parkinson’s care.
Halia Therapeutics Named as 2025 Top 10 Longevity Breakthrough Award Winner
BioSeeker mapped more than 10,000 isolates and identified targetable regions that provide 100% strain coverage across the viral family.
Biolexis Therapeutics Initiates First-in-Human Clinical Trials for Novel, Oral Muscle-Sparing, Weight Loss and Type 2 Diabetes Therapies
FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Atopic Dermatitis in Children Ages 2 to 5
This week AdvaMed held its annual Medtech Conference, designed for those in the medical technology industry.
The State of Innovation Conference, hosted by The Nucleus Institute, brought together entrepreneurs, investors, policymakers, and researchers to explore pathways, partnerships, and funding strategies for breakthrough technologies. The day began with keynote speaker Jerry Hollister, who spoke on federal innovation funding trends, followed by a panel highlighting Utah companies that had successfully leveraged SBIR/STTR awards, […]
Nelson Labs on October 1 celebrated a milestone 40th anniversary. Since its humble beginnings in 1985 in University of Utah’s Research Park, Nelson Labs has grown into a trusted, global leader of medical device and pharmaceutical testing.
September 30, Salt Lake City—In a groundbreaking collaboration between ARUP Laboratories and the University of Utah, the new Advanced Practice Clinical Laboratory Training Center opened its doors this week and took a bold step toward solving a nationwide shortage of clinical laboratory scientists. This state-of-the-art facility is more than a training site; it’s a model […]
Glafabra Therapeutics, Uncommon Cures Collaborate to Advance Fabry Disease Therapy
Seek Labs Selected as Participant of ARPA-H Investor Catalyst Hub Spoke Network and Rapid Response Partnership Vehicle (RRPV)
Innovative Wearable for Pelvic Floor Health by Freyya Completes Clinical Study
Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy
The Memorandum of Understanding includes the formation of a Joint Venture in the Kingdom of Saudi Arabia for manufacturing and distribution of the Company’s upcoming Co-Dx™ PCR platform and other Co-Dx IP
Definitive agreement to accelerate adoption of Renalytix’s FDA-approved, Medicare reimbursed kidneyintelX.dkd test to slow kidney disease progression and improve patient outcomes
KUDA THERAPEUTICS AWARDED $5.6M U.S. DoD GRANT TO BRING LEAD ONCOLOGY CANDIDATE INTO CLINIC
ARUP Achieves Reaccreditation Under College of American Pathologists ISO 15189 Program
Study will begin enrollment in Q1 2026 in the US and UK and leverage the BIOFIRE® SPOTFIRE® point-of-care diagnostics platform at U.S. sites.
Owlet’s new release creates the ultimate baby monitoring system for video, sleep, and medical-grade health tracking.
BioUtah Member Appreciation BBQ 2025 Recap
Kimbell & Associates: Trump Administration Issues MAHA Strategy Report of Recommendations to President Trump
If approved, ZORYVE cream would be the first and only topical PDE4 inhibitor indicated for plaque psoriasis in children as young as 2.
Salt Lake City Angels Invests in Freyya
